Warning letter
Trone Health Services, Inc.: warning letter of Mar 22, 2017
FDA warning letter 514999 · Seattle District Office
Key facts
| Reference number | 514999 |
|---|---|
| Company | Trone Health Services, Inc. |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Mar 22, 2017 |
| Posted date | Apr 4, 2017 |
| Issuing office | Seattle District Office |
| Product type | Drugs |
| Inspection city | Meridian |
| Inspection ZIP | 83642 |
| Inspection start date | Jun 27, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: